Also, as several publications mentioned the possibility of COX-2 measurement in serum [12,13], future studies should examine serum COX-2 levels in CRC patients to determine a cut-off value for determining which patients may have worse outcomes than the others. Here, PTGS2 is linked to colorectal carcinoma.